Table 2.

Changes in clinical and laboratory variables following heart failure therapy

	Admission	After HF therapy	P
Systolic BP mm Hg*	113±20	109 ± 15	0.121
Diastolic BP mm Hg*	68±14	66±10	0.290
Heart rate, bpm*	83±16	80±13	0.189
Hemoglobin, gr/dL*	12.5±2.3	12.1±2.1	0.061
Sodium, mg/dL*	137±6.1	136±5.2	0.210
Potassium, mg/dL*	4.5±0.6	4.3±0.4	0.002
BUN, mg/dL *	29.8±19.3	32.6±19.9	0.022
Creatinine, mg/dL*	1.15±0.4	1.21 ± 0.4	0.193
Albumin, mg/dL*	3.8±0.6	3.7±0.5	0.077
NT-proBNP pg/mL**	4343 (1730-9858)	3298 (1030-9528)	0.001
cTnI, ng/mL**	0.030 (0.010-0.077)	0.030 (0.010-0.067)	0.408
LVEF, %*	25.4±6.1	26.5±6.3	0.001
sPAP mm Hg*	43.4±19	39.2±11	0.001

^*mean±SD, Paired t test,

^**median(Quartiles), Wilcoxon signed-rank test

BP - blood pressure; BUN - blood urea nitrogen; cTn - cardiac troponin-I; LVEF - left ventricular ejection fraction; NT-proBNP - N-terminal pro-brain natriuretic peptide; sPAP - systolic pulmonary arterial pressure